PD-1 Inhibitor Immune-Related Adverse Events in Patients With Preexisting Endocrine Autoimmunity.

التفاصيل البيبلوغرافية
العنوان: PD-1 Inhibitor Immune-Related Adverse Events in Patients With Preexisting Endocrine Autoimmunity.
المؤلفون: Akturk, Halis Kaan, Alkanani, Aimon, Zhao, Zhiyuan, Yu, Liping, Michels, Aaron W
المصدر: The Journal of Clinical Endocrinology & Metabolism; October 2018, Vol. 103 Issue: 10 p3589-3592, 4p
مستخلص: Immune checkpoint inhibitors, including monoclonal antibodies directed against programmed cell death protein 1 (PD-1) and its ligand, have emerged as beneficial cancer immunotherapies. These therapies are known to cause immune-related side effects; however, their role in patients with a preexisting autoimmune disease is not clear.
قاعدة البيانات: Supplemental Index
الوصف
تدمد:0021972X
19457197
DOI:10.1210/jc.2018-01430